AxoGen, Inc. $AXGN Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase and Co. cut its holdings in shares of AxoGen, Inc. (NASDAQ: AXGN) by 44.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 209,003 shares of the medical equipment provider's stock after selling 170,067 shares during the quarter. JPMorgan Chase and